Nalaganje...
Phase I study of selinexor, ixazomib and low-dose dexamethasone in patients with relapsed or refractory multiple myeloma
Shranjeno v:
| izdano v: | Clin Lymphoma Myeloma Leuk |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7405911/ https://ncbi.nlm.nih.gov/pubmed/32001193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2019.12.013 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|